These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30807659)

  • 1. Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasis.
    Yaribeygi H; Atkin SL; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(10):16966-16970. PubMed ID: 30807659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes.
    Hörbelt T; Tacke C; Markova M; Herzfeld de Wiza D; Van de Velde F; Bekaert M; Van Nieuwenhove Y; Hornemann S; Rödiger M; Seebeck N; Friedl E; Jonas W; Thoresen GH; Kuss O; Rosenthal A; Lange V; Pfeiffer AFH; Schürmann A; Lapauw B; Rudovich N; Pivovarova O; Ouwens DM
    Diabetologia; 2018 Sep; 61(9):2054-2065. PubMed ID: 29754289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WISP1 is a novel adipokine linked to inflammation in obesity.
    Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
    Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
    Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
    J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WISP1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus.
    Sahin Ersoy G; Altun Ensari T; Subas S; Giray B; Simsek EE; Cevik O
    J Matern Fetal Neonatal Med; 2017 Apr; 30(8):942-946. PubMed ID: 27267804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Wnt1-inducible Signaling Pathway Protein-1 in Obese Children and Adolescents.
    Wang AR; Yan XQ; Zhang C; Du CQ; Long WJ; Zhan D; Ren J; Luo XP
    Curr Med Sci; 2018 Oct; 38(5):868-874. PubMed ID: 30341522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update to the WISP-1/CCN4 Role in Obesity, Insulin Resistance and Diabetes.
    Mirr M; Owecki M
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33498604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
    Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
    World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights for Oxidative Stress and Diabetes Mellitus.
    Maiese K
    Oxid Med Cell Longev; 2015; 2015():875961. PubMed ID: 26064426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WISP1: Clinical insights for a proliferative and restorative member of the CCN family.
    Maiese K
    Curr Neurovasc Res; 2014; 11(4):378-89. PubMed ID: 25219658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study.
    Klinke DJ
    PLoS Comput Biol; 2014 Jan; 10(1):e1003409. PubMed ID: 24426833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation.
    Almario RU; Karakas SE
    Horm Metab Res; 2015 Feb; 47(2):152-7. PubMed ID: 25089371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
    Gurbuz I; Chiquet-Ehrismann R
    Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.
    Ferrand N; Béreziat V; Moldes M; Zaoui M; Larsen AK; Sabbah M
    Sci Rep; 2017 May; 7(1):1749. PubMed ID: 28496206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Serum WISP1 Levels are Associated with Lower Extremity Atherosclerotic Disease in Patients with Type 2 Diabetes Mellitus.
    Cheng Y; Du X; Zhang B; Zhang J
    Exp Clin Endocrinol Diabetes; 2022 Apr; 130(4):248-253. PubMed ID: 33930896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity.
    Pivovarova-Ramich O; Loske J; Hornemann S; Markova M; Seebeck N; Rosenthal A; Klauschen F; Castro JP; Buschow R; Grune T; Lange V; Rudovich N; Ouwens DM
    Cells; 2021 Apr; 10(5):. PubMed ID: 33946738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WISP1 induces ovarian cancer via the IGF1/αvβ3/Wnt axis.
    Li Y; Wang F; Liu T; Lv N; Yuan X; Li P
    J Ovarian Res; 2022 Aug; 15(1):94. PubMed ID: 35964060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WISP 1 is an important survival factor in human mesenchymal stromal cells.
    Schlegelmilch K; Keller A; Zehe V; Hondke S; Schilling T; Jakob F; Klein-Hitpass L; Schütze N
    Gene; 2014 Nov; 551(2):243-54. PubMed ID: 25200494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wisp1 mediates Bmp3-stimulated mesenchymal stem cell proliferation.
    Cernea M; Tang W; Guan H; Yang K
    J Mol Endocrinol; 2016 Jan; 56(1):39-46. PubMed ID: 26489765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.